Elicio Therapeutics Inc (ELTX)

Feb 13, 2025

How to Take Advantage of moves in (ELTX) - Stock Traders Daily

Feb 13, 2025

Feb 12, 2025

Clal Biotech Completes Elicio Divestment and Initiates Loan Repayment - TipRanks

Feb 12, 2025

Feb 03, 2025

Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025

Feb 03, 2025

Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025

Jan 31, 2025

Elicio Therapeutics secures $10 million in direct offering - MSN

Jan 31, 2025

Jan 31, 2025

Elicio: Lymph Node Binding With ELI-002 Could Lead To Substantial 1st Half 2025 Data - Seeking Alpha

Jan 31, 2025

Jan 30, 2025

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jan 30, 2025

Jan 30, 2025

Elicio Therapeutics Raises Fresh Capital: $10M Strategic Funding Deal Includes Bonus Warrants - StockTitan

Jan 30, 2025

Jan 23, 2025

Elicio Therapeutics Advances with New Clinical Updates - TipRanks

Jan 23, 2025

Jan 23, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 23, 2025

Jan 23, 2025

FDA Supports Registrational Strategy for ELI-002 in KRAS-Driven Cancers - Targeted Oncology

Jan 23, 2025

Jan 22, 2025

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy - The Manila Times

Jan 22, 2025

Jan 22, 2025

Elicio Therapeutics Secures FDA Support for ELI-002 Cancer Therapy Phase 3 Strategy - StockTitan

Jan 22, 2025

Jan 22, 2025

(ELTX) Investment Report - Stock Traders Daily

Jan 22, 2025

Jan 21, 2025

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 21, 2025

Jan 17, 2025

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 17, 2025

Jan 14, 2025

Serina Therapeutics Appoints Former Jazz Pharmaceuticals Finance Executive Karen Wilson to Board - StockTitan

Jan 14, 2025

Jan 08, 2025

Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews

Jan 08, 2025

Jan 01, 2025

Trading (ELTX) With Integrated Risk Controls - Stock Traders Daily

Jan 01, 2025

Dec 13, 2024

Elicio Therapeutics Advances ELI-002 and Secures Funding - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

Elicio reports promising cancer vaccine trial results By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 12, 2024

Elicio Therapeutics Presents Updated Results from ELI-002 - GlobeNewswire

Dec 12, 2024

Dec 12, 2024

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO - The Bakersfield Californian

Dec 12, 2024

Dec 12, 2024

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 - Business Upturn

Dec 12, 2024

Dec 11, 2024

(ELTX) Investment Analysis and Advice - Stock Traders Daily

Dec 11, 2024

Dec 04, 2024

Elicio completes phase 2 enrollment for cancer vaccine By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 03, 2024

Elicio completes phase 2 enrollment for cancer vaccine - Investing.com India

Dec 03, 2024

Dec 03, 2024

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment - GlobeNewswire

Dec 03, 2024

Dec 03, 2024

Elicio Therapeutics Completes Phase 2 Trial Enrollment for Pancreatic Cancer Treatment - StockTitan

Dec 03, 2024

Nov 22, 2024

SEC Form 424B3 filed by Elicio Therapeutics Inc. - Quantisnow

Nov 22, 2024

Nov 14, 2024

Elicio Therapeutics: Q3 Earnings Snapshot - mySA

Nov 14, 2024

Nov 13, 2024

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Nov 13, 2024

Nov 07, 2024

Elicio Therapeutics adjourns annual meeting due to lack of quorum - Investing.com

Nov 07, 2024

Nov 07, 2024

Elicio reports promising Phase 1 cancer vaccine trial results - Investing.com India

Nov 07, 2024

Nov 07, 2024

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study - The Bakersfield Californian

Nov 07, 2024

Nov 07, 2024

Elicio Therapeutics adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK

Nov 07, 2024

Nov 01, 2024

Jones Trading Initiates Coverage of Elicio Therapeutics (ELTX) with Buy Recommendation - MSN

Nov 01, 2024

Oct 31, 2024

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit - The Manila Times

Oct 31, 2024

Oct 31, 2024

Elicio Therapeutics to Present Clinical Data at the Society - GlobeNewswire

Oct 31, 2024

Oct 24, 2024

All You Need to Know About Elicio Therapeutics (ELTX) Rating Upgrade to Strong Buy - Yahoo Finance

Oct 24, 2024

Oct 17, 2024

Elicio Therapeutics announces new CFO and accounting officer By Investing.com - Investing.com Australia

Oct 17, 2024

Oct 17, 2024

Elicio Therapeutics announces new CFO and accounting officer - Investing.com

Oct 17, 2024

Oct 16, 2024

Elicio Therapeutics reports inducement grants - TipRanks

Oct 16, 2024

Oct 16, 2024

Elicio Therapeutics Reports Inducement Grants - GlobeNewswire

Oct 16, 2024